Accéder au contenu
Merck

A novel dual luciferase based high throughput assay to monitor autophagy in real time in yeast

Biochemistry and biophysics reports (2017-09-29)
Piyush Mishra, Shashank Rai, Ravi Manjithaya
RÉSUMÉ

Macroautophagy is a cellular response to starvation wherein superfluous and damaged cytoplasmic constituents are degraded to provide energy for survival and to maintain cellular homeostasis. Dysfunctional autophagy is attributed to disease progression in several pathological conditions and therefore, autophagy has appeared as a potential pharmacological target for such conditions. In search of potential drugs that modulate autophagy, identifying small molecule effectors of autophagy is the primary step. The conventional autophagy assays have a limitation that they cannot be scaled down to a high throughput format, therefore, novel sensitive assays are needed to discover new candidate molecules. Keeping this rationale in mind, a dual luciferase based assay was developed in the yeast Firefly and The assay was more sensitive than conventional assays and could be scaled down to a 384 well format using an automated system. A good Z-factor score indicated that the assay is highly suitable for High Throughput Screening (HTS) of small molecule libraries. Screening of a small molecule library with our assay identified several known and novel modulators of autophagy.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anti-Renilla Luciferase Antibody, clone 5B11.2, ascites fluid, clone 5B11.2, Chemicon®
Sigma-Aldrich
Anti-Mouse IgG−Atto 550 antibody produced in goat, 1 mg/mL protein
Sigma-Aldrich
Anti-Rabbit-IgG - Atto 550 antibody produced in goat